While the prevalence and the use of new psychoactive substances (NPS) is steadily increasing, data on pharmacological, toxicological and clinical effects is limited. Considering the large number of NPS available, there is a clear need for efficient in vitro screening techniques that capture multiple mechanisms of action. Neuronal cultures grown on multi-well microelectrode arrays (mwMEAs) have previously proven suitable for neurotoxicity screening of chemicals, pharmaceuticals and (illicit) drugs. We therefore used rat primary cortical cultures grown on mwMEA plates to investigate the effects of eight NPS (PMMA, a-PVP, methylone, MDPV, 2C-B, 25B-NBOMe, BZP and TFMPP) and two 'classic' illicit drugs (cocaine, methamphetamine) on spontaneous neuronal activity.
Introduction
Over the past 5 years, the proportion of the general population (15-64 years) that used a drug at least once has been stable at approximately 5% (UNODC, 2017) . The most widely used class of drugs remains cannabinoids, although its use is stabilizing or even declining in parts of Europe. The second most used class of drugs are the amphetamines and their use, particularly methamphetamine, has been increasing in some European countries (UNODC, 2017) . The use of amphetamines accounts for a considerable share of the estimated 28 million 'healthy' life years lost by drug use in 2015 (disability-adjusted life years (DALYs)). Of all amphetamines, methamphetamine contributes most to the global burden of disease, and an increasing number of methamphetamine users are seeking treatment (UNODC, 2017) .
New psychoactive substances (NPS), also known as 'legal highs', 'bath salts' or 'research chemicals', appeared on the drug market around a decade ago. Even though they account for only a small proportion of the market, NPS encompass a group of over 700 different substances. These potentially harmful drugs are manufactured to have intended effects comparable to those of illegal drugs like amphetamine, lysergic acid diethylamide (LSD), ketamine and 3,4-methylenedioxymethamphetamine (MDMA). The potential of NPS to cause harm is at least partly due to the inexperience of users with regards to e.g., dosing or routes of administration. In addition, the pharmacological and toxicological mechanisms of these drugs are often not fully elucidated (Hondebrink et al., 2018) . Drug users also may have been taken NPS unknowingly, as NPS were sometimes used as adulterants in more commonly used illicit drugs (EMCDDA, 2016) . For example, in the Netherlands high doses of para-methoxymethamphetamine (PMMA) were detected in ecstasy tablets, for which health alerts were issued (Van der Gouwe and Rigter, 2017) . Over the last years, however, NPS are becoming a 'drug of choice' instead of being adulterants (UNODC, 2017) . Although around 100 NPS are reported to monitoring centers for the first time annually, only a core group of over 80 NPS have been reported every year since 2009. Some of the NPS that stayed on the market, like alpha-pyrrolidinovalerophenone (a-PVP), benzylpiperazine (BZP), 3,4-methylenedioxypyrovalerone (MDPV), mephedrone, methylone and PMMA, have now been classified as illegal drugs by authorities in several countries including the UK, Canada, Australia and many European countries (UNODC, 2017) .
In 2014, the life-time prevalence of NPS use for young European adults (15-24 years) was 8% (European commission, 2014) . In vulnerable groups (homeless, young people, people with mental health issues, men who sleep with men, and people who inject drugs) this number was as high as 59% (MacLeod et al., 2016) . In addition, according to a survey among NPS users, 30% had used nine or more NPS during the last five years compared to 15% who only used one NPS. Further, 76% of NPS users who tried more than one NPS were inclined to use NPS from different classes (Soussan and Kjellgren, 2016) .
Even though NPS are becoming increasingly popular, surveys have shown that most young people think that regular NPS use has a high health risk. However, only 50% of young people think that high risks are involved when NPS are used only once or twice, while 10% think there is no or a low risk (European Commission, 2014) . Nevertheless, the emergence of NPS has been associated with severe intoxications and fatalities (UNODC, 2017) . Compounds mimicking the hallucinogenic effects of LSD (which are therefore sometimes sold as LSD), for instance 2C-B and especially its NBOMe derivatives, have caused intoxications and even fatalities (Wood et al., 2015) . In addition, in 2015 a-PVP was linked to 63 deaths and over 1800 hospital emergency admissions in only one county in Florida (ACC, 2015) .
Analogues to' classic' illicit drugs, most NPS exert their intended effects at least partly by increasing brain monoamine levels. Illicit drugs and NPS can increase dopamine, norepinephrine and serotonin levels by blocking and/or reversing the dopamine, norepinephrine and serotonin reuptake transporters (Zwartsen et al., 2017; Rickli et al., 2015; Simmler et al., 2013) . In addition, several other mechanisms of action are contributing to the effects of NPS, including (ant)agonistic effects on multiple neurotransmitter receptors (e.g. GABA A , NMDA, 5-HT 2 and ACh) and/or inhibition of ion channels (e.g. voltage-gated calcium channels) (see Hondebrink et al., 2018 for review) .
While knowledge of effects of NPS on single endpoints is valuable, the increasing number of NPS illustrates the need for efficient in vitro screening techniques that capture multiple mechanisms of action. Recently, neuronal cultures grown on microelectrode arrays (MEAs) have proven to be suitable for neurotoxicity screening of pharmaceuticals, toxins, chemicals and (illicit) drugs (Strickland et al., 2018; Vassallo et al., 2017; Hondebrink et al., 2016; Nicolas et al., 2014; Valdivia et al., 2014; McConnell et al., 2012; Puia et al., 2012) . Using this method, valuable information can be obtained quickly by investigating effects on neuronal activity as an integrated endpoint of underlying effects on all targets affected within the neuronal network, including different ion channels, neurotransmitter receptors and compensatory mechanisms.
As the prevalence and use of NPS is continuously increasing, we investigated the acute effects of 10 NPS and' classic' illicit drugs on spontaneous neuronal activity at human relevant concentrations. The tested NPS and illicit drugs were chosen based on continued presence on the drug market. Compounds were categorized based on chemical similarities for characterization purposes; i.e. amphetamine-type stimulants (methamphetamine and PMMA), hallucinogenic phenethylamines (2C-B and 25B-NBOMe), cathinones (methylone, MDPV and a-PVP), piperazines (BZP and TFMPP) and others (cocaine).
Methods

Chemicals
D-Methamphetamine, methylone, PMMA, 2C-B, 25B-NBOMe, a-PVP, MDPV, BZP and TFMPP hydrochloride salts (purity > 98.5%) were purchased from Lipomed (Weil am Rhein, Germany). Cocaine (purity > 98.5) was obtained from Spruyt Hillen (IJsselstein, the Netherlands) (for IUPAC names see Table 1 ). Neurobasal-A (NBA) medium, L-glutamine (200 mM), Penicillin/streptomycin (5000 U/mL/5000 mg/mL), fetal bovine serum (FBS) and B-27 supplement (without vitamin A) were obtained from Life Technologies (Bleiswijk, The Netherlands). All other chemicals, unless otherwise noted, were purchased from Sigma-Aldrich (Zwijndrecht, The Netherlands). Stock solutions of drugs were prepared at the day of the experiment in FBS medium, unless otherwise specified.
Neuronal cultures
Rat pups born of timed-pregnant Wistar rats (Envigo, Horst, the Netherlands) were used on postnatal day 0-1 to isolate cortical neurons. Cortical cultures were prepared as described previously (Hondebrink et al., 2016) . Briefly, cortices were isolated, minced with scalpels, triturated and filtered through a 100 mm mesh (EASYstrainer, Greiner) to get a homogenous cell suspension in dissection medium consisting of 500 mL Neurobasal-A supplemented with 14 g sucrose, 1.25 mL L-glutamine (200 mM), 5 mL glutamate (3.5 mM), 5 mL penicillin/streptomycin and 50 mL FBS (osmolarity of $330 mOsm). Subsequently, cells were centrifuged for 5 min at 800 rpm, the supernatant was removed and the pellet was resuspended using 1 mL of dissection medium per rat brain and diluted to a cell suspension containing 2 Â 10 6 cells/mL. Next, a 50 mL drop of cell suspension was added to each well (1 Â10 5 cells/well) of a 48-wells MEA plate (Axion BioSystems Inc, Atlanta, USA, M768-GL1-30Pt200) coated with PEI (0.1% PEI solution in borate buffer (24 mM sodium borate/ 50 mM boric acid in Milli-Q adjusted to pH 8.4)). Cells were allowed to attach for 2 h at 37 C, 5% CO 2 /95% air atmosphere before 450 mL dissection medium was added to each well. The day after the isolation (day in vitro 1; DIV1) 450 mL/well of the dissection medium was replaced with the same amount of glutamate medium (500 mL NBA medium, 14 g sucrose, 1.25 mL L-glutamine (200 mM), 5 mL glutamate (3.5 mM), 5 mL penicillin/ streptomycin and 10 mL B-27, pH 7.4 (osmolarity of $330 mOsm)).
At DIV4, 450 mL/well glutamate medium was replaced with 450 mL/ well FBS medium (glutamate-free dissection medium (osmolarity of $330 mOsm)). Cultures were kept in FBS medium at 37 C, 5% CO 2 /95% air atmosphere until use at DIV9-10.
Animal experiments were performed in agreement with Dutch law, the European Community directives regulating animal research (2010/63/EU) and approved by the Ethical Committee for Animal Experiments of Utrecht University. All efforts were made to minimize the number of animals used and their suffering.
MEA recordings
At DIV9-10, mwMEA plates (48 wells with 16 individual embedded nanotextured gold microelectrodes per well ($40-50 mm diameter; 350 mm center-to-center spacing)) were placed in a Maestro 768-channel amplifier with integrated heating system, temperature controller and data acquisition interface (Axion BioSystems Inc, Atlanta, USA) to record spontaneous neuronal activity. Prior to each recording, the plate was allowed to equilibrate for 2-5 min. Baseline spontaneous neuronal activity was recorded for 30 min. Following the baseline recording, all wells were exposed individually by manually pipetting 5 mL FBS medium with or without (control) drugs, under sterile conditions. Next, a 30 min exposure recording was started to determine the effects of drugs on spontaneous neuronal activity. The following substances and concentrations were tested: methamphetamine, methylone, BZP and TFMPP (1-1000 mM), 2C-B and a-PVP (1-300 mM), cocaine (1-100 mM) and PMMA (10-1000 mM; also see Table 1 ).
Due to solubility limitations of MDPV and 25B-NBOMe, wells were exposed individually by manually pipetting 55 mL FBS medium with MDPV (1-1000 mM) or without (control for MDPV), or 55 mL 10% Hanks' balanced salt solution ((HBSS)/90% Neurobasal-A) medium with 25B-NBOMe (1-30 mM) or without (control for 25B-NBOMe; also see Table 1 ). The tested concentrations for each substance were based on range finding experiments starting with 1, 10 and 100 mM, if solubility allowed. To prevent possible effects of cumulative dosing, including receptor (de)sensitization, each well was exposed to only a single substance at a single concentration. For each experimental condition, primary cultures from at least two different isolations (average 4 isolations) were used and tested in at least 5 plates (average 7 plates). The number of wells represents the number of replicates per condition.
Data analysis and statistics
After recording neuronal activity, raw data files were re-recorded using AxIS spike detector (Adaptive threshold crossing, Ada BandFlt v2) to map the spikes. Spikes were defined by >7xSD of the internal noise level (rms) with a post/pre spike duration of 3.6/2.4 ms of each individual electrode. Spike information was then further analyzed Table 1 Characteristics of the tested illicit drugs and NPS.
'Exposure volume' indicates the volume that is added to each MEA well during exposure recording.
* Due to solubility issues with these NPS, the exposure volume, maximum concentration and/or exposure medium were different. # FBS medium: 500 mL Neurobasal-A medium supplemented with 14 g sucrose, 1.25 mL L-glutamine (200 mM), 5 mL penicillin/streptomycin and 50 mL Fetal bovine serum, HBSS: Hanks' balanced salt solution, NB-A: Neural basal A medium.
using NeuroExplorer1 (Nex Technologies, Madison (AL), US) and custom-made macros in Excel (for workflow see Fig. 1 ).
To analyze effects of NPS and illicit drugs on weighted mean firing rate (wMFR) or weighted mean burst rate (wMBR), only wells that contained !1 active electrode (with !0.1 spike/sec) in the baseline recording were included. On average, each well contained 7 active electrodes. Bursts were defined using the Poisson surprise method (minimum of 10 surprises). All tested drugs induced effects rapidly following exposure and effects lasted the entire exposure recording. The wMFR and wMBR from the last 10 min (most stable timeframe; Hondebrink et al., 2016) of the 30 min exposure recording was therefore used for analysis. Effects of test compounds on wMFR or wMBR were analyzed as follows:
First, the wMFR and wMBR were calculated per well prior to exposure (the reference activity, wMFR baseline or wMBR baseline ). Next, the wMFR and wMBR were calculated per well following exposure (wMFR exposure or wMBR bexposure ). Subsequently, wMFR exposure was expressed as a percentage of wMFR baseline (and wMBR exposure vs wMBR baseline ) of the same well to obtain a treatment ratio (paired comparison, see Fig. 1 for workflow) . Treatment ratios were also calculated for control wells that were exposed only to medium during the exposure recording. Then treatment ratios (wMFR exposure as a percentage of wMFR baseline or wMBR exposure as a percentage of wMBR baseline ) were sorted per condition per compound (e.g., 10 mM methylone). Wells with treatment ratios > mean AE 2xSD (of their respective condition) were considered outliers and excluded (4.3%). Finally, the average Fig. 1 . Schematic illustration of the collection and analysis of neuronal network activity. Spontaneous network activity is recorded for 30 min using the Maestro and Axion Biosystems hardware. Using Axion software, recordings were re-recorded to generate spike count files. Subsequently, active baseline wells were selected in the selected timeframes using NeuroExplorer software and the listed criteria. Then, custom-made macro's were used to calculate treatment ratio's, remove outliers, and finalize calculations. wMFR: weighted mean firing rate, wMBR: weighted mean burst rate.
control treatment ratio was set to 100% and treatment ratios of individual exposed wells were normalized to the average treatment ratio of medium control wells. Treatment ratios of exposed wells were averaged per condition per compound and used for further statistical analysis. To determine the robustness of the selection criteria for inclusion of active wells, a separate analysis was performed in which only wells with !9 active electrodes were included (also see Supplemental Results).
GraphPad Prism software (v6, GraphPad Software, La Jolla CA, USA) was used for data analysis. Non-linear regressions were used to calculate IC 50 values. When applicable, a one-way ANOVA followed by a post-hoc Dunnet's test was used to compare treatment ratios in drug-exposed wells to treatment ratios in control wells. Effects on neuronal activity (wMFR and wMBR) were considered relevant when the effect was statistically significant (p < 0.05) and !30%. The lowest observed effect concentration (LOEC) was defined as the lowest concentration that induced a relevant inhibiting effect. Data is shown as mean AE SEM for n wells , N plates from at least two different isolations.
Calculation of estimated human brain concentrations following recreational drug use
The estimated human brain concentration range was calculated for methamphetamine, cocaine and PMMA according to Zwartsen et al. (2017) . Estimated human brain concentrations of other substances were obtained from Hondebrink et al., 2018 . In short, a recreational methamphetamine blood concentration range of 0.05-20 mM was established based on data from literature on apprehended drivers, people arrested for criminal activity or partygoers (Jones et al., 2008; Melega et al., 2007; Irvine et al., 2006) . The blood concentration range was multiplied by the brain partition factor (1.0-2.8), which was based on 11 human case reports on lethal methamphetamine exposures that reported blood and brain concentrations (Kiely et al., 2009; Chaturvedi et al., 2004; Saito et al., 1996; Hara et al., 1986; Kojima et al., 1984) . The estimated brain concentration after recreational use was calculated to be 0.05-56 mM for methamphetamine.
The reported blood concentration after recreational cocaine use was between 0.01-3.0 mM (Senna et al., 2010; Steentoft et al., 2010 ). An estimated brain concentration of 0.02-30 mM was determined by multiplying the recreational blood concentration by a brain partition factor of 1.7-10, which was based on human blood and brain concentrations obtained post-mortem (Brajkovic et al., 2016; Giroud et al., 2004; Kiszka and Madro, 2004; Poklis et al., 1987 Poklis et al., , 1985 .
Blood concentrations after (un)intentional consumption of PMMA found in literature ranged from 0.1-3.6 mM (Vevelstad et al., 2012) . Based on rat studies (serum to brain and plasma to brain) a brain partition factor of 4.1-16 (Pálenícek et al., 2011; Rohanova and Balikova, 2009 ) was used to determine an estimated brain concentration of 0.4-58 mM. 
Results
Effect of drugs and NPS on neuronal activity
Spontaneous electrical activity in primary rat cortical cultures develops within the first week of in vitro culture and optimal activity is reached around DIV10 (Dingemans et al., 2016) . We therefore exposed rat cortical cultures on DIV9-10 to determine the effects of two' classical' illicit drugs and eight NPS on neuronal activity. Following baseline recording, active wells were exposed for 30 min to different concentrations of cocaine, methamphetamine, PMMA, methylone, MDPV, a-PVP, 2C-B, 25B-NBOMe, BZP and TFMPP. Each well was exposed to only a single concentration of test compound to prevent possible effects of cumulative dosing, including receptor (de)sensitization. Concentration-response curves for effects on wMFR were obtained by comparing the treatment ratios (wMFR exposure vs wMFR baseline ) of wells exposed to different concentrations of a particular drug to the treatment ratio of the control wells on matching plates. While wMFR is a sensitive and robust parameter that is suitable for evaluation of chemical effects on neuronal activity (Novellino et al., 2011) , it may not adequately reflect changes in the pattern of spike activity such as changes in the weighted mean burst rate (wMBR). Rat primary cortical networks grown on MEAs show distinct bursts that are synchronized over the entire network in the well, as shown in Fig. 2 . Analogous to wMFR, we therefore also constructed concentration-response curves for the effects of the different drugs on wMBR. In general, all drugs concentration-dependently inhibited neuronal activity (Figs. 3-6 ).
Cocaine and amphetamine-type stimulants
The amphetamine-type stimulants (ATS) methamphetamine and PMMA inhibited wMFR with IC 50 values of 100 mM and 112 mM, respectively (Fig. 3) . wMBR IC 50 values (IC 50 values of 123 and 104 mM, respectively) were comparable to those for wMFR.
Cocaine was $10 times more potent with an wMFR IC 50 value of 9.8 mM and a wMBR IC 50 value of 13 mM. Similarly, cocaine completely abolished neuronal activity at a concentration 10 times lower than methamphetamine or PMMA. The inhibitory LOEC values (both wMFR and wMBR) for cocaine, methamphetamine and PMMA were close to IC 50 values and were 10 mM, 100 mM and 100 mM, respectively.
Cathinones
The cathinones MDPV and a-PVP inhibited wMFR with IC 50 values of 29 mM and 21 mM, respectively (Fig. 4) . The IC 50 values for wMBR were 28 mM for a-PVP and 14 mM for MDPV. Both NPS completely abolished neuronal activity at 100 mM. Methylone was $10 times less potent compared to MDPV and a-PVP (wMFR IC 50 value of 235 mM and wMBR IC 50 value of 246 mM) and completely inhibited neuronal activity at 1 mM. The inhibitory wMFR and wMBR LOEC values for methylone were 300 mM, 100 mM (wMFR) and 30 mM (wMBR) for MDPV and a-PVP had inhibitory LOEC values of 30 mM. Fig. 3 . Concentration-response curves of cocaine and two amphetamine-type stimulants for the weighted mean firing rate (wMFR, solid line) and the weighted mean burst rate (wMBR, dotted). (A) Cocaine (wMFR n wells = 25-30, N plates = 6-8, wMBR n wells = 24-28, N plates = 6-8), (B) methamphetamine (wMFR n wells = 23-29, N plates = 3-8, wMBR n wells = 22-28, N plates = 3-8) and (C) PMMA (wMFR n wells = 25-32, N plates = 5-8, wMBR n wells = 23-30, N plates = 5-8). Neuronal activity is depicted as the mean treatment ratio AE SEM (wMFR exposure /wMFR baseline and wMBR exposure /wMBR baseline as % of control wells). Effects 30% (i.e. variation of medium control) are considered not to be of (toxicological) relevance, as is depicted by the grey area. * (wMFR) and # (wMBR) indicate a relevant and statistically significant (p > 0.05) effect. a-PVP (wMFR n wells = 26-33, N plates = 6-8, wMBR n wells = 22-31, N plates = 6-8). Neuronal activity is depicted as the mean treatment ratio AE SEM (change in wMFR baseline / wMBR baseline and wMFR exposure /wMBR exposure as % of control wells). Effects 30% (i.e. variation of medium control) are considered not to be of (toxicological) relevance, as is depicted by the grey area. * (wMFR) and # (wMBR) indicate a relevant and statistically significant (p > 0.05) effect.
Hallucinogenic phenethylamines
The hallucinogenic phenethylamine 25B-NBOMe inhibited both wMFR and wMBR more potently compared to 2C-B (Fig. 5) ; a 10-fold difference is observed between wMFR IC 50 values (2.4 mM and 27 mM, respectively) and a 10-fold difference is seen between wMBR IC 50 values (3.3 mM and 39 mM, respectively). The concentration at which neuronal activity is completely inhibited also showed a 10-fold difference; 10 mM for 25B-NBOMe vs 100 mM for 2C-B. The inhibitory wMFR and wMBR LOEC values for 25B-NBOMe and 2C-B amounted to 3 and 10 mM, and 30 and 100 mM, respectively. Also a significant slight increase in the wMBR is seen at low concentrations of 25B-NBOMe (0.1 and 0.3 mM).
Piperazines
The piperazine derivatives BZP and TFMPP also inhibited wMFR and wMBR in a comparable manner; a 10-fold difference in IC 50 values was observed between these compounds (wMFR IC 50 values of 161 mM and 19 mM, respectively, and wMBR IC 50 values of 207 mM and 24 mM, respectively) (Fig. 6) . This difference in IC 50 values was also reflected in the difference between complete inhibition of the neuronal networks (1 mM and 100 mM, respectively) and the inhibitory wMFR and wMBR LOEC values for BZP and TFMPP (300 mM and 30 mM, respectively).
Effects on wMBR
Exposure to NPS or classical drugs thus not only induced a profound decrease in wMFR, but also resulted in a concentrationdependent decrease in wMBR (Figs. 3-6) . In general, all drugs show comparable IC 50 values for wMBR and wMFR (Table 2) . Notably, the parallel decline in both wMFR and wMBR may suggests that the total number of spikes within bursts remained largely unaffected.
Effects of electrode selection based on activity
We have previously shown that the concentration-response curves of a set of drugs were largely independent of the baseline spike frequency. For example, including only electrodes with higher MFR for analysis of drug-induced effects on wMFR (0.1 Hz versus 1 Hz) did not change the concentration-response curves (Hondebrink et al., 2016) . We now also investigated if changing the selection criteria for active wells (more active electrodes per well) affects the results. Notably, no difference was observed in the concentration-response curves between analysis with wells with ! 1 active electrode and analysis with wells with !9 active electrodes (see Supplemental Results), highlighting the robustness of the mwMEA approach.
Discussion
We recently used rat cortical cultures grown on mwMEA to derive proof of principle for its usability as an efficient screening tool to determine the effects of (illicit) drugs on spontaneous neuronal activity (Hondebrink et al., , 2016 . The present study elaborates on this successful proof of principle by investigating the effects of an additional 10 different illicit drugs and NPS. Analogous to our previous findings, all tested drugs inhibited neuronal activity (weighted mean firing rate (wMFR)) with wMFR IC 50 values ranging from 2.4 mM for 25B-NBOMe to 234 mM for methylone. A comparable range was observed for inhibition of the weighted mean burst rate (wMBR; IC 50 3.3 mM for 25B-NBOMe to IC 50 246 mM for methylone). The similarity in concentrationresponse curves for wMFR and wMBR suggests that the number of spikes per burst may be unaffected (also see sample trace in Fig. 2) . Notably, our data also demonstrate that the results are largely independent of the number of active electrodes/well (Supplemental Results). This also implies that implementation of higher throughput 96-well MEA plates (with 8 electrodes/well) or even future 384-well MEA plates (with only 2 electrodes/well) would likely not affect the results if neuronal networks show synchronized activity.
Importantly, the observed broad range of IC 50 values hints to the possible existence of distinct structure-activity relationships (SARs). By including data from our previous studies, we are able to compare the effects of 16 illicit drugs and NPS from different classes on spontaneous neuronal activity (wMFR ; Table 3 ). Firstly, all amphetamine-type stimulants (amphetamine, methamphetamine, MDMA, PMMA and 4-FA) inhibit the wMFR with IC 50 values of $100 mM. Small changes in the chemical structure of this group, like the addition of a fluorine atom, and a methoxy or methylenedioxy structure, do not change their potency to inhibit the wMFR (Table 3 and Fig. 7) . Nonetheless, these structural changes might influence distribution and clearance in vivo.
Secondly, the addition of a ketone group to the MDMA structure, resulting in the cathinone methylone, decreases the potency of the compound to inhibit the wMFR 2-fold (IC 50 values 106 mM vs 234 mM, respectively; Fig. 7) . On the other hand, the . Neuronal activity is depicted as the mean treatment ratio AE SEM (change in wMFR baseline /wMBR baseline and wMFR exposure /wMBR exposure as % of control wells). Effects 30% (i.e. variation of medium control) are considered not to be of (toxicological) relevance, as is depicted by the grey area. * (wMFR) and # (wMBR) indicate a relevant and statistically significant (p > 0.05) effect. Neuronal activity is depicted as the mean treatment ratio AE SEM (change in wMFR baseline /wMBR baseline andw MFR exposure /wMBR exposure as % of control wells). IC 50 values (mM) are presented with 95% confidence intervals [CI] . Effects 30% (i.e. variation of medium control) are considered not to be of (toxicological) relevance, as is depicted by the grey area. * (wMFR) and # (wMBR) indicate a relevant and statistically significant (p > 0.05) effect.
cathinones MDPV and a-PVP (IC 50 values of 29 mM and 21 mM, respectively) are $10-fold more potent than methylone, and $5 times more potent than amphetamine-type stimulants. This may be due to the addition of a pyrrolidine structure, a secondary cyclic amine. This notion is further supported by the potent inhibition by cocaine (IC 50 value 9.8 mM), which contains a tropane structure that includes a pyrrolidine structure. Again, the presence or absence of a methylenedioxy group (MDPV and a-PVP, respectively) did not significantly change IC 50 values, confirming earlier findings on the (lack of) contribution of the methylenedioxy group in MDMA compared to methamphetamine (Fig. 7) .
In addition, other subclasses of (illicit) drugs also showed differences in wMFR IC 50 values of compounds within the same group. For example, the hallucinogenic phenethylamines 2C-B and 25B-NBOMe differ $10-fold in IC 50 values (27 mM vs 2.4 mM, respectively), while chemically only varying by the addition of a NBOMe (methoxybenzyl) group (Fig. 6) . A comparable difference is seen between the piperazines BZP (IC 50 value of 161 mM), and TFMPP and mCPP (IC 50 values of 19 mM and 32 mM, respectively).
This increase is most likely due to the addition of a halogen moiety on the phenyl ring, as halogens have been reported to enhance binding to target macromolecules (Dembinski et al., 2012) . 50 and LOEC values for the inhibition of the weighted mean firing rate (wMFR) and weighted mean burst rate (wMBR) of 8 NPS and 2 illicit drugs.
IC 50 values (mM) are presented with 95% confidence intervals [CI] . LOEC: lowest observed effect concentration. However, an increased potency to inhibit wMFR is not seen when comparing amphetamine and 4-FA.
Finally, of all compounds tested, the arylcyclohexylamines ketamine and methoxetamine (MXE) most potently inhibited wMFR with comparable IC 50 values of 1.2 mM and 0.5 mM, respectively (Table 3; Hondebrink et al., 2017) . Others have reported a near complete inhibition of the MFR at 200 mM ketamine in a single concentration screening approach (McConnell et al., 2012) . However, data on the effects of other drugs of abuse and NPS on wMFR and the wMBR from other laboratories, especially concentration-response curves, are rare, which hampers further comparison.
The present results, derived from an acute 30 min exposure, are unlikely to be confounded by effects on cell viability. Earlier studies showed no loss of viability when rat primary cortical cultures were exposed to up to 1 mM to structurally related compounds such as MDMA, amphetamine, 4-FA and MXE, whereas the piperazine analogue mCPP only showed minor effects on cell viability at 300 mM (Hondebrink et al., 2016) . However, additional information on the reversibility of the effects and potential effects on cell viability following acute or prolonged exposure would aid in further pharmacological characterization of NPS. Nevertheless, our combined findings already provide a first step towards increasing knowledge on the relationship between chemical structures and drug effects for NPS. Still, more information on the effects on neuronal activity of various NPS belonging to different classes is needed for a robust (Q)SAR that could aid in risk reduction by in silico modelling.
Using the mwMEA, it is possible to quickly detect effects of NPS on neuronal activity as an integrated neuronal endpoint. When looking at IC 50 values for wMFR and wMBR, most drugs inhibited half of the spontaneous neuronal activity at concentrations relevant for human exposure (Table 3) . However, the IC 50 values of 4-FA, methylone, a-PVP, 2C-B, 25B-NBOMe and BZP are well above the estimated human relevant brain concentration range. For BZP, this concentration is likely underestimated, since the brain partition factor was assumed to be 1 (brain concentration is the same as blood concentration) due to missing data. However, other piperazine derivatives show a rather high brain partition factor. Assuming a similar brain partition factor for BZP as for other piperazine derivatives would put the BZP-induced inhibition of neuronal activity (IC 50 ) in the range of concentrations relevant for human exposure (Hondebrink et al., 2018) . Notably, the use of serum-containing medium in our experiments may have affected the free drug concentration. However, in our calculation of relevant human brain concentrations, we used blood concentrations of drug users in whom serum is also present.
Cortical cultures grown on mwMEA plates express a large number of functional targets and thus provide a useful integrated screening method for in vitro neurotoxicity testing (Vassallo et al., 2017; Hondebrink et al., 2016) . MEA recordings thus represent the sum of the effects on all targets present in the model system. Nevertheless, some specific targets with a strict (extracortical) location in the brain, such as specific neurotransmitter receptors or transporters, are likely underrepresented in our in vitro model. This could also explain why some of the investigated drugs have IC 50 values for inhibition of neuronal activity above the estimated human brain concentrations. For example, monoamine reuptake transporters are inhibited by 4-FA, methylone, a-PVP and BZP at relevant concentrations (Hondebrink et al., 2018) , while neuronal activity is not (Table 3) . Similarly, 2C-B and 25B-NBOMe are presumed to primarily act as 5-HT 2 receptor agonists (Hondebrink et al., 2018) , whereas in neonatal Wistar rat cortex only 5-HT 2A and 5-HT 2C receptor subtypes are expressed to some extent (Osredkar and Krzan, 2009 ). Consequently, risk and hazard characterization of NPS should involve integrated screening methods such as MEA recordings as well as dedicated assays to determine effects on specific targets such as monoamine reuptake transporters and serotonin/dopamine receptors (also see Hondebrink et al., 2018) .
Overall, the number of NPS is increasing steadily while limited information is available regarding their pharmacology and toxicology. The 16 drugs tested in this study and our earlier ) studies belong to various drug classes and could therefore have different mechanisms of action, which would make targeted screening approaches laborious. Using mwMEA recordings, all 16 drugs tested showed concentrationdependent inhibition of spontaneous neuronal activity, with different potency but mostly within estimated human brain concentrations based on recreational use. mwMEA recordings may therefore provide a first step in linking chemical structures and drug classes to establish SARs, even before NPS appear on the drug market. Moreover, mwMEA recordings can thus provide an efficient integrated screening method that will aid in risk and hazard characterization of NPS, especially when the mechanism(s) of action are a priori unknown.
